SEI INVESTMENTS CO - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 81 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$534,000
-25.4%
32,950
+31.3%
0.00%
-50.0%
Q3 2021$716,000
+6.2%
25,091
+25.8%
0.00%
+100.0%
Q2 2021$674,000
+16.6%
19,951
+4.5%
0.00%0.0%
Q1 2021$578,000
-26.1%
19,101
+21.0%
0.00%
-50.0%
Q4 2020$782,000
+112.5%
15,786
+64.7%
0.00%
+100.0%
Q3 2020$368,000
+1.1%
9,582
+13.8%
0.00%0.0%
Q2 2020$364,000
+61.1%
8,423
-2.8%
0.00%0.0%
Q1 2020$226,0008,6630.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 2,104,278$55,890,0004.98%
SCOPIA CAPITAL MANAGEMENT LP 1,587,566$42,166,0000.81%
DC Investments Management, LLC 25,000$664,0000.45%
Monashee Investment Management LLC 67,800$1,801,0000.38%
Avoro Capital Advisors LLC 310,000$8,234,0000.38%
Cormorant Asset Management, LP 200,000$5,312,0000.34%
PURA VIDA INVESTMENTS, LLC 22,350$594,0000.12%
Artal Group S.A. 150,000$3,984,0000.10%
OXFORD ASSET MANAGEMENT LLP 59,122$1,556,0000.03%
Point72 Hong Kong Ltd 3,252$86,0000.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders